ArticleJBMR plus2019

Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva-Derived Endothelial Cells.

Gonzalo Sánchez-Duffhues et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.